Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Safety and Efficacy of Concomitant Erenumab and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients

Safety of Concomitant Triptan and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients

Investigating the Impact of Virtual Versus In-Person Small Group Discussion on Academic Performance in a First-Year Medical Neuroscience Course

Investigating the Risk of Hypertension After Initiation of Erenumab in the Post-Market Setting

Adherence and Persistence among Patients with Migraine Initiating Concomitant Use of Self-Injectable Calcitonin Gene-related Peptide Monoclonal Antibody and Novel Acute Migraine Medications